{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:13:12Z","timestamp":1773339192338,"version":"3.50.1"},"reference-count":40,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2026.13100","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:20:12Z","timestamp":1770722412000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["IGFBP1 as a metabolic\u2011neurodegenerative biomarker in spinocerebellar ataxia type 3"],"prefix":"10.3892","volume":"31","author":[{"given":"Chungmin","family":"Chiu","sequence":"first","affiliation":[{"name":"Department of Chinese Medicine, Changhua Christian Hospital, Changhua 50006, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenling","family":"Cheng","sequence":"additional","affiliation":[{"name":"Vascular and Genomic Center, Institute of ATP, Changhua Christian Hospital, Changhua 50006, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsung","family":"Lin","sequence":"additional","affiliation":[{"name":"Vascular and Genomic Center, Institute of ATP, Changhua Christian Hospital, Changhua 50006, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiju","family":"Chang","sequence":"additional","affiliation":[{"name":"Center of Regenerative Medicine and Tissue Repair, Institute of ATP, Changhua Christian Hospital, Changhua 50006, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujun","family":"Chang","sequence":"additional","affiliation":[{"name":"Big Data Center, Changhua Christian Hospital, Changhua 50006, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihli","family":"Su","sequence":"additional","affiliation":[{"name":"Vascular Medicine and Diabetes Research Center, Institute of ATP, Changhua Christian Hospital, Changhua 50006, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaju","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Changhua Christian Hospital, Changhua 50006, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henhong","family":"Chang","sequence":"additional","affiliation":[{"name":"Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung 40447, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinsan","family":"Liu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung 40447, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"key20260312100933_b1-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ecl.2012.11.008","article-title":"Integrating metabolism and longevity through insulin and IGF1 signaling","volume":"42","author":"Sadagurski","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"14882","key":"key20260312100933_b2-ETM-31-4-13100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914882","article-title":"The IGF1 signaling pathway: From basic concepts to therapeutic opportunities","volume":"24","author":"Werner","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20260312100933_b3-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11010-019-03560-5","article-title":"Receptor tyrosine kinases (RTKs) consociate in regulatory clusters in Alzheimer's disease and type 2 diabetes","volume":"459","author":"Majumder","year":"2019","journal-title":"Mol Cell Biochem"},{"issue":"213","key":"key20260312100933_b4-ETM-31-4-13100","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00213","article-title":"Neurodegenerative diseases-is metabolic deficiency the root cause?","volume":"14","author":"Muddapu","year":"2020","journal-title":"Front Neurosci"},{"key":"key20260312100933_b5-ETM-31-4-13100","author":"Paulson"},{"key":"key20260312100933_b6-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12311-022-01507-z","article-title":"Association between serum neurofilament light chain and neurochemistry deficits in patients with spinocerebellar ataxia type 3","volume":"23","author":"Chen","year":"2024","journal-title":"Cerebellum"},{"issue":"e11803","key":"key20260312100933_b7-ETM-31-4-13100","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911803","article-title":"Neurofilaments in spinocerebellar ataxia type 3: Blood biomarkers at the preataxic and ataxic stage in humans and mice","volume":"12","author":"Wilke","year":"2020","journal-title":"EMBO Mol Med"},{"key":"key20260312100933_b8-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/mds.23428","article-title":"Serum insulin-like system alterations in patients with spinocerebellar ataxia type 3","volume":"26","author":"Saute","year":"2011","journal-title":"Mov Disord"},{"key":"key20260312100933_b9-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ana.410390310","article-title":"The insulin-like growth factor I system in cerebellar degeneration","volume":"39","author":"Torres-Aleman","year":"1996","journal-title":"Ann Neurol"},{"key":"key20260312100933_b10-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/BF00399934","article-title":"Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy","volume":"35","author":"Crosby","year":"1992","journal-title":"Diabetologia"},{"key":"key20260312100933_b11-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1006\/nbdi.2000.0311","article-title":"Neurodegeneration is associated to changes in serum insulin-like growth factors","volume":"7","author":"Busiguina","year":"2000","journal-title":"Neurobiol Dis"},{"key":"key20260312100933_b12-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00075197-200205000-00006","article-title":"Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection","volume":"5","author":"Lang","year":"2002","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"key20260312100933_b13-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbrc.2020.05.116","article-title":"Growth hormone rescue cerebellar degeneration in SCA3 transgenic mice","volume":"529","author":"Wu","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"key20260312100933_b14-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/mds.23423","article-title":"Subcutaneous insulin-like growth factor-1 treatment in spinocerebellar ataxias: An open label clinical trial","volume":"26","author":"Arpa","year":"2011","journal-title":"Mov Disord"},{"issue":"505","key":"key20260312100933_b15-ETM-31-4-13100","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020505","article-title":"IGF-1 as a potential therapy for spinocerebellar ataxia type 3","volume":"10","author":"Lin","year":"2022","journal-title":"Biomedicines"},{"key":"key20260312100933_b16-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","article-title":"Scale for the assessment and rating of ataxia: Development of a new clinical scale","volume":"66","author":"Schmitz-H\u00fcbsch","year":"2006","journal-title":"Neurology"},{"key":"key20260312100933_b17-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12311-018-0929-2","article-title":"Association between body mass index and disease severity in Chinese spinocerebellar ataxia type 3 patients","volume":"17","author":"Yang","year":"2018","journal-title":"Cerebellum"},{"issue":"e0178614","key":"key20260312100933_b18-ETM-31-4-13100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178614","article-title":"Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens","volume":"12","author":"Alehagen","year":"2017","journal-title":"PLoS One"},{"key":"key20260312100933_b19-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3969\/j.issn.1672-7347.2011.06.005","article-title":"Related factors of ICARS and SARA scores on spinocerebellar ataxia type 3\/Machado-Joseph disease","volume":"36","author":"Zhou","year":"2011","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"39","key":"key20260312100933_b20-ETM-31-4-13100","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0338-0","article-title":"Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3","volume":"14","author":"Li","year":"2019","journal-title":"Mol Neurodegener"},{"key":"key20260312100933_b21-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1212\/WNL.0000000000001711","article-title":"The preclinical stage of spinocerebellar ataxias","volume":"85","author":"Maas","year":"2015","journal-title":"Neurology"},{"issue":"23","key":"key20260312100933_b22-ETM-31-4-13100","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-3-23","article-title":"Correlation between measures of insulin resistance in fasting and non-fasting blood","volume":"3","author":"Hancox","year":"2011","journal-title":"Diabetol Metab Syndr"},{"issue":"317","key":"key20260312100933_b23-ETM-31-4-13100","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02948-3","article-title":"A pilot study: Handgrip as a predictor in the disease progression of SCA3","volume":"18","author":"Chiu","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"key20260312100933_b24-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","article-title":"Correct homeostasis model assessment (HOMA) evaluation uses the computer program","volume":"21","author":"Levy","year":"1998","journal-title":"Diabetes Care"},{"key":"key20260312100933_b25-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"1575156","key":"key20260312100933_b26-ETM-31-4-13100","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1575156","article-title":"Glucagon-like peptide-1, fibroblast growth factor 21, and other endocrine responses to alcohol ingestion in women before and after metabolic surgery","volume":"16","author":"Molina-Castro","year":"2025","journal-title":"Front Pharmacol"},{"key":"key20260312100933_b27-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1210\/edrv.18.6.0321","article-title":"Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions","volume":"18","author":"Rajaram","year":"1997","journal-title":"Endocr Rev"},{"key":"key20260312100933_b28-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3181\/00379727-204-43630","article-title":"Regulation and function of insulin-like growth factor-binding protein-1","volume":"204","author":"Lee","year":"1993","journal-title":"Proc Soc Exp Biol Med"},{"key":"key20260312100933_b29-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1203\/01.PDR.0000156369.62787.96","article-title":"Early developmental changes in IGF-I, IGF-II, IGF binding protein-1, and IGF binding protein-3 concentration in the cerebrospinal fluid of children","volume":"58","author":"Bunn","year":"2005","journal-title":"Pediatr Res"},{"issue":"1178626419842176","key":"key20260312100933_b30-ETM-31-4-13100","doi-asserted-by":"publisher","DOI":"10.1177\/1178626419842176","article-title":"The role of insulin-like growth factors and insulin-like growth factor-binding proteins in the nervous system","volume":"12","author":"Lewitt","year":"2019","journal-title":"Biochem Insights"},{"key":"key20260312100933_b31-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1093\/hmg\/ddx224","article-title":"Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes","volume":"26","author":"Ramani","year":"2017","journal-title":"Hum Mol Genet"},{"key":"key20260312100933_b32-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1523\/JNEUROSCI.1954-20.2021","article-title":"Impaired oligodendrocyte maturation is an early feature in SCA3 disease pathogenesis","volume":"42","author":"Schuster","year":"2022","journal-title":"J Neurosci"},{"key":"key20260312100933_b33-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/jnen\/62.10.1006","article-title":"Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3","volume":"62","author":"Evert","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"key20260312100933_b34-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ghir.2015.09.001","article-title":"IGFBP-1 predicts all-cause mortality in elderly women independently of IGF-I","volume":"25","author":"Nolte","year":"2015","journal-title":"Growth Horm IGF Res"},{"key":"key20260312100933_b35-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/1028415X.2018.1469282","article-title":"Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group","volume":"23","author":"Leite","year":"2020","journal-title":"Nutr Neurosci"},{"key":"key20260312100933_b36-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"7344","DOI":"10.1523\/JNEUROSCI.15-11-07344.1995","article-title":"In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: Studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice","volume":"15","author":"Ye","year":"1995","journal-title":"J Neurosci"},{"key":"key20260312100933_b37-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1900\/RDS.2020.16.24","article-title":"Insulin-like growth factor and its therapeutic potential for diabetes complications-mechanisms and metabolic links: A review","volume":"16","author":"Biadgo","year":"2020","journal-title":"Rev Diabet Stud"},{"issue":"438","key":"key20260312100933_b38-ETM-31-4-13100","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01734-1","article-title":"IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson's disease models","volume":"9","author":"Arcos","year":"2023","journal-title":"Cell Death Discov"},{"key":"key20260312100933_b39-ETM-31-4-13100","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00401-020-02183-1","article-title":"Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregates","volume":"140","author":"Garc\u00eda-Huerta","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"105311","key":"key20260312100933_b40-ETM-31-4-13100","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105311","article-title":"Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia","volume":"153","author":"Coarelli","year":"2021","journal-title":"Neurobiol Dis"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:09:38Z","timestamp":1773302978000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2026.13100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2,10]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2026.13100","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}